176 related articles for article (PubMed ID: 38011562)
1. PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis.
Manetsch P; Böhi F; Nowak K; Leslie Pedrioli DM; Hottiger MO
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2309047120. PubMed ID: 38011562
[TBL] [Abstract][Full Text] [Related]
2. PARP7 mono-ADP-ribosylates the agonist conformation of the androgen receptor in the nucleus.
Kamata T; Yang CS; Paschal BM
Biochem J; 2021 Aug; 478(15):2999-3014. PubMed ID: 34264286
[TBL] [Abstract][Full Text] [Related]
3. Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling.
Kamata T; Yang CS; Melhuish TA; Frierson HF; Wotton D; Paschal BM
Cells; 2021 Feb; 10(2):. PubMed ID: 33572475
[TBL] [Abstract][Full Text] [Related]
4. PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells.
Rasmussen M; Tan S; Somisetty VS; Hutin D; Olafsen NE; Moen A; Anonsen JH; Grant DM; Matthews J
Cells; 2021 Mar; 10(3):. PubMed ID: 33799807
[TBL] [Abstract][Full Text] [Related]
5. Quantification of PARP7 Protein Levels and PARP7 Inhibitor Target Engagement in Cells Using a Split Nanoluciferase System.
Duell AK; Sanderson DJ; Cohen MS
Methods Mol Biol; 2023; 2609():387-395. PubMed ID: 36515849
[TBL] [Abstract][Full Text] [Related]
6. PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.
Gozgit JM; Vasbinder MM; Abo RP; Kunii K; Kuplast-Barr KG; Gui B; Lu AZ; Molina JR; Minissale E; Swinger KK; Wigle TJ; Blackwell DJ; Majer CR; Ren Y; Niepel M; Varsamis ZA; Nayak SP; Bamberg E; Mo JR; Church WD; Mady ASA; Song J; Utley L; Rao PE; Mitchison TJ; Kuntz KW; Richon VM; Keilhack H
Cancer Cell; 2021 Sep; 39(9):1214-1226.e10. PubMed ID: 34375612
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TCDD-inducible poly-ADP-ribose polymerase (TIPARP/ARTD14) catalytic activity.
Gomez A; Bindesbøll C; Satheesh SV; Grimaldi G; Hutin D; MacPherson L; Ahmed S; Tamblyn L; Cho T; Nebb HI; Moen A; Anonsen JH; Grant DM; Matthews J
Biochem J; 2018 Dec; 475(23):3827-3846. PubMed ID: 30373764
[TBL] [Abstract][Full Text] [Related]
8. Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer Cells.
Yang C; Wierbiłowicz K; Dworak NM; Bae SY; Tengse SB; Abianeh N; Drake JM; Abbas T; Ratan A; Wotton D; Paschal BM
Cancer Res Commun; 2023 Apr; 3(4):592-606. PubMed ID: 37077937
[TBL] [Abstract][Full Text] [Related]
9. Reduced Colonic Mucosal Injury in 2,3,7,8-Tetrachlorodibenzo-
Hutin D; Hagen KA; Shao P; Sugamori K; Grant DM; Matthews J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055106
[TBL] [Abstract][Full Text] [Related]
10. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
[TBL] [Abstract][Full Text] [Related]
11. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
[TBL] [Abstract][Full Text] [Related]
12. Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity.
Rasmussen M; Alvik K; Kannen V; Olafsen NE; Erlingsson LAM; Grimaldi G; Takaoka A; Grant DM; Matthews J
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509350
[TBL] [Abstract][Full Text] [Related]
13. Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression.
Yau L; Litchie B; Thomas S; Storie B; Yurkova N; Zahradka P
Eur J Biochem; 2003 Jan; 270(1):101-10. PubMed ID: 12492480
[TBL] [Abstract][Full Text] [Related]
14. Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis.
Zhang S; Duan J; Yang Y; Gong H; Tang Y; Xiao M; Li M; Li Q; Wang Y
Med Oncol; 2021 Aug; 38(9):111. PubMed ID: 34357465
[TBL] [Abstract][Full Text] [Related]
15. Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly.
Yang CS; Jividen K; Kamata T; Dworak N; Oostdyk L; Remlein B; Pourfarjam Y; Kim IK; Du KP; Abbas T; Sherman NE; Wotton D; Paschal BM
Nat Commun; 2021 May; 12(1):2705. PubMed ID: 33976187
[TBL] [Abstract][Full Text] [Related]
16. Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells.
Palavalli Parsons LH; Challa S; Gibson BA; Nandu T; Stokes MS; Huang D; Lea JS; Kraus WL
Elife; 2021 Jan; 10():. PubMed ID: 33475085
[TBL] [Abstract][Full Text] [Related]
17. Methods to Study TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP) Mono-ADP-Ribosyltransferase Activity.
Hutin D; Grimaldi G; Matthews J
Methods Mol Biol; 2018; 1813():109-124. PubMed ID: 30097864
[TBL] [Abstract][Full Text] [Related]
18. ADP-Ribosylation Regulates the Signaling Function of IFN-γ.
Menzel S; Koudelka T; Rissiek B; Haag F; Meyer-Schwesinger C; Tholey A; Koch-Nolte F
Front Immunol; 2021; 12():642545. PubMed ID: 33763084
[TBL] [Abstract][Full Text] [Related]
19. Function and regulation of the mono-ADP-ribosyltransferase ARTD10.
Kaufmann M; Feijs KL; Lüscher B
Curr Top Microbiol Immunol; 2015; 384():167-88. PubMed ID: 24878761
[TBL] [Abstract][Full Text] [Related]
20. A role of intracellular mono-ADP-ribosylation in cancer biology.
Scarpa ES; Fabrizio G; Di Girolamo M
FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
